|
1
|
Hinchey J, Chaves C, Appignani B, Breen J,
Pao L, Wang A, Pessin MS, Lamy C, Mas JL and Caplan LR: A
reversible posterior leukoencephalopathy syndrome. N Engl J Med.
334:494–500. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lamy C, Oppenheim C and Mas JL: Posterior
reversible encephalopathy syndrome. Handb Clinical Neurol.
121:1687–1701. 2014. View Article : Google Scholar
|
|
3
|
Lamy C, Oppenheim C, Meder JF and Mas JL:
Neuroimaging in posterior reversible encephalopathy syndrome. J
Neuroimaging. 14:89–96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fugate JE, Claassen DO, Cloft HJ, Kallmes
DF, Kozak OS and Rabinstein AA: Posterior reversible encephalopathy
syndrome: Associated clinical and radiologic findings. Mayo Clin
Proc. 85:427–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartynski WS: Posterior reversible
encephalopathy syndrome, part 2: Controversies surrounding
pathophysiology of vasogenic edema. AJNR Am J Neuroradiol.
29:1043–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Covarrubias DJ, Luetmer PH and Campeau NG:
Posterior reversible encephalopathy syndrome: Prognostic utility of
quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol.
23:1038–1048. 2002.PubMed/NCBI
|
|
7
|
Hunt SM, McKenna SP, McEwen J, Backett EM,
Williams J and Papp E: A quantitative approach to perceived health
status: A validation study. J Epidemiol Community Health.
34:281–286. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
ter Laan M, van Dijk JM, Elting JW, Staal
MJ and Absalom AR: Sympathetic regulation of cerebral blood flow in
humans: A review. Br J Anaesth. 111:361–367. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartynski WS: Posterior reversible
encephalopathy syndrome, part 1: Fundamental imaging and clinical
features. AJNR Am J Neuroradiol. 29:1036–1042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Casey SO, Sampaio RC, Michel E and Truwit
CL: Posterior reversible encephalopathy syndrome: Utility of
fluid-attenuated inversion recovery MR imaging in the detection of
cortical and subcortical lesions. AJNR Am J Neuroradiol.
21:1199–1206. 2000.PubMed/NCBI
|
|
11
|
Schwartz RB, Feske SK, Polak JF,
DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY and
Repke JT: Preeclampsia-eclampsia: Clinical and neuroradiographic
correlates and insights into the pathogenesis of hypertensive
encephalopathy. Radiology. 217:371–376. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Engelter ST, Provenzale JM and Petrella
JR: Assessment of vasogenic edema in eclampsia using diffusion
imaging. Neuroradiology. 42:818–820. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Provenzale JM, Petrella JR, Cruz LC Jr,
Wong JC, Engelter S and Barboriak DP: Quantitative assessment of
diffusion abnormalities in posterior reversible encephalopathy
syndrome. AJNR Am J Neuroradiol. 22:1455–1461. 2001.PubMed/NCBI
|
|
14
|
Teive HA, Brandi IV, Camargo CH,
Bittencourt MA, Bonfim CM, Friedrich ML, de Medeiros CR, Werneck LC
and Pasquini R: Reversible posterior leucoencephalopathy syndrome
associated with bone marrow transplantation. Arq Neuropsiquiatr.
59:784–789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glusker P, Recht L and Lane B: Reversible
posterior leukoencephalopathy syndrome and bevacizumab. N Engl J
Med. 354:980–982, Disscussion 980–982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wong R, Beguelin GZ, de Lima M, Giralt SA,
Hosing C, Ippoliti C, Forman AD, Kumar AJ, Champlin R and Couriel
D: Tacrolimus-associated posterior reversible encephalopathy
syndrome after allogeneic haematopoietic stem cell transplantation.
Br J Haematol. 122:128–134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Won SC, Kwon SY, Han JW, Choi SY and Lyu
CJ: Posterior reversible encephalopathy syndrome in childhood with
hematologic/oncologic diseases. J Pediatr Hematol Oncol.
31:505–508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartynski WS, Zeigler ZR, Shadduck RK and
Lister J: Pretransplantation conditioning influence on the
occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic
bone marrow transplantation. AJNR Am J Neuroradiol. 25:261–269.
2004.PubMed/NCBI
|
|
19
|
Fukuyama T, Tanaka M, Nakazawa Y, Motoki
N, Inaba Y, Higuchi T and Koike K: Prophylactic treatment for
hypertension and seizure in a case of allogeneic hematopoietic stem
cell transplantation after posterior reversible encephalopathy
syndrome. Pediatr Transplant. 15:E169–E173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blazar BR and Murphy WJ: Bone marrow
transplantation and approaches to avoid graft-versus-host disease
(GVHD). Philos Trans R Soc Lond B Biol Sci. 360:1747–1767. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bartynski WS, Tan HP, Boardman JF, Shapiro
R and Marsh JW: Posterior reversible encephalopathy syndrome after
solid organ transplantation. AJNR Am J Neuroradiol. 29:924–930.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartynski WS, Zeigler ZR, Shadduck RK and
Lister J: Variable incidence of cyclosporine and FK-506
neurotoxicity in hematopoeitic malignancies and marrow conditions
after allogeneic bone marrow transplantation. Neurocrit Care.
3:33–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rouquette-Gally AM, Boyeldieu D, Gluckman
E, Abuaf N and Combrisson A: Autoimmunity in 28 patients after
allogeneic bone marrow transplantation: Comparison with Sjögren
syndrome and scleroderma. Br J Haematol. 66:45–47. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pruitt AA, Graus F and Rosenfeld MR:
Neurological complications of transplantation: Part I:
Hematopoietic cell transplantation. Neurohospitalist. 3:24–38.
2013. View Article : Google Scholar : PubMed/NCBI
|
